BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35646645)

  • 1. Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System.
    Meng Q; Wang W; Liu X; Wang D; Zhang F
    Front Oncol; 2022; 12():870670. PubMed ID: 35646645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
    Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
    Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    PLoS One; 2019; 14(4):e0214498. PubMed ID: 30986236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System.
    Yang X; An J; Zhang Y; Yang Y; Chen S; Huang M; Wu L
    Front Oncol; 2020; 10():591700. PubMed ID: 33194752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
    BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System.
    Liu X; Wang W; Hu K; Zhang F; Hou X; Yan J; Meng Q; Zhou Z; Miao Z; Guan H; Ma J; Shen J; Zhen H; Wang W
    Sci Rep; 2020 Jan; 10(1):362. PubMed ID: 31941966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis.
    Yi J; Liu Z; Wang L; Zhang X; Pi L; Zhou C; Mu H
    Front Oncol; 2022; 12():857375. PubMed ID: 35372011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram prediction for overall survival of patients diagnosed with cervical cancer.
    Polterauer S; Grimm C; Hofstetter G; Concin N; Natter C; Sturdza A; Pötter R; Marth C; Reinthaller A; Heinze G
    Br J Cancer; 2012 Sep; 107(6):918-24. PubMed ID: 22871885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
    Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
    Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
    Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
    Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer: a Korean Radiation Oncology Group study (KROG 13-03).
    Lee HJ; Han S; Kim YS; Nam JH; Kim HJ; Kim JW; Park W; Kim BG; Kim JH; Cha SD; Kim J; Lee KH; Yoon MS; Kim SM; Kim JY; Yoon WS; Lee NW; Choi JH; Park SY; Kim JY
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):659-64. PubMed ID: 24138914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study.
    Xie G; Wang R; Shang L; Qi C; Yang L; Huang L; Yang W; Chung MC
    BMC Cancer; 2020 Sep; 20(1):833. PubMed ID: 32873257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram Predicting Overall Survival in Patients With Locally Advanced Cervical Cancer Treated With Radiochemotherapy Including Image-Guided Brachytherapy: A Retro-EMBRACE Study.
    Sturdza AE; Pötter R; Kossmeier M; Kirchheiner K; Mahantshetty U; Haie-Meder C; Lindegaard JC; Jurgenliemk-Schulz I; Tan LT; Hoskin P; van Limbergen E; Gillham C; Segedin B; Tharavichitkul E; Iturre EV; Fokdal LU; Polterauer S; Kirisits C; Tanderup K
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):168-177. PubMed ID: 33932530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of serum tumor-markers based nomogram to predict the prognostic value of patients with cervical adenocarcinoma.
    Liu Y; Shi L; Chen K; Ye W
    Curr Probl Cancer; 2022 Dec; 46(6):100899. PubMed ID: 36270166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
    Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
    Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: A large multicenter study.
    Tang X; Guo C; Liu S; Guo J; Hua K; Qiu J
    Int J Gynaecol Obstet; 2021 Oct; 155(1):86-94. PubMed ID: 33587753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
    Wang B; Wang S; Ren W
    BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
    Zang L; Chen Q; Zhang X; Zhong X; Chen J; Fang Y; Lin A; Wang M
    Cancer Manag Res; 2021; 13():9391-9400. PubMed ID: 35002316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.